We are live on ! Find out more
MKC

M. Kraus & Co Portfolio holdings

AUM $343M
1-Year Est. Return 19.86%
This Fund
S&P 500
This Quarter Est. Return
+3.52%
1 Year Est. Return
+19.86%
3 Year Est. Return
+45.35%
5 Year Est. Return
+60.2%
10 Year Est. Return
+237.02%
AUM
$145M
AUM Growth
+$4.72M
Cap. Flow
-$398K
Cap. Flow %
-0.27%
Top 10 Hldgs %
38.07%
Holding
52
New
2
Increased
12
Reduced
32
Closed
2

Top Buys

Rank Stock Value
1
MET icon
MetLife
MET
+$1.07M
2
COP icon
ConocoPhillips
COP
+$733K
3
MDT icon
Medtronic
MDT
+$408K
4
GE icon
GE Aerospace
GE
+$297K
5
CHD icon
Church & Dwight Co
CHD
+$276K

Top Sells

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$263K
2
BMY icon
Bristol-Myers Squibb
BMY
+$263K
3
DUK icon
Duke Energy
DUK
+$210K
4
LHX icon
L3Harris
LHX
+$195K
5
SE
Spectra Energy Corp Wi
SE
+$194K

Sector Composition

Rank Sector Weight
1 Industrials 22.29%
2 Healthcare 18.47%
3 Consumer Staples 17.28%
4 Technology 8.63%
5 Financials 6.85%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
COP icon
26
ConocoPhillips
COP
$141B
$2.57M 1.78%
59,163
+17,650
+43% +$733K
DCI icon
27
Donaldson
DCI
$10.8B
$2.39M 1.65%
63,989
-3,155
-5% -$115K
IBM icon
28
IBM
IBM
$204B
$2.26M 1.56%
14,898
-430
-3% -$65.3K
CPN
29
DELISTED
Calpine Corporation
CPN
$1.91M 1.32%
151,020
-8,814
-6% -$119K
XOM icon
30
ExxonMobil
XOM
$642B
$1.91M 1.32%
21,849
-100
-0.5% -$8.87K
CVX icon
31
Chevron
CVX
$378B
$1.76M 1.22%
17,150
-475
-3% -$48.5K
KMI
32
DELISTED
KINDER MORGAN,INC
KMI
$1.04M 0.72%
44,855
-585
-1% -$13.5K
PFE icon
33
Pfizer
PFE
$141B
$812K 0.56%
25,270
-625
-2% -$20.9K
GLD icon
34
SPDR Gold Trust
GLD
$132B
$787K 0.54%
6,264
-156
-2% -$19.9K
VTI icon
35
Vanguard Total Stock Market ETF
VTI
$655B
$546K 0.38%
4,908
– –
MRK icon
36
Merck
MRK
$323B
$525K 0.36%
8,823
-69
-0.8% -$4.04K
MMM icon
37
3M
MMM
$91.9B
$472K 0.33%
3,203
+3
+0.1% +$448
AMGN icon
38
Amgen
AMGN
$203B
$413K 0.29%
2,473
-105
-4% -$17.8K
T
39
DELISTED
A T & T CORP (NEW)
T
$382K 0.26%
9,410
+8
+0.1% +$325
KO icon
40
Coca-Cola
KO
$362B
$355K 0.25%
8,388
-93
-1% -$4.08K
MCD icon
41
McDonald's
MCD
$192B
$273K 0.19%
2,368
– –
JPM icon
42
JPMorgan Chase
JPM
$947B
$243K 0.17%
3,642
+4
+0.1% +$261
AAPL icon
43
Apple
AAPL
$4.95T
$227K 0.16%
+8,028
New +$212K
BRK.A icon
44
Berkshire Hathaway Class A
BRK.A
$1.07T
$216K 0.15%
100
– –
VZ icon
45
Verizon
VZ
$198B
$211K 0.15%
4,053
+2
+0% +$107
PM icon
46
Philip Morris
PM
$305B
$209K 0.14%
2,150
– –
SPY icon
47
State Street SPDR S&P 500 ETF Trust
SPY
$781B
$201K 0.14%
+931
New +$201K
BMY icon
48
Bristol-Myers Squibb
BMY
$128B
– –
-3,570
Closed -$263K
DUK icon
49
Duke Energy
DUK
$100B
– –
-2,444
Closed -$210K
1
2

Similar funds

AWA
Acorn Wealth Advisors Grand Blanc, Michigan $343M AUM 15.24% 1-Year Est. Return
LKIM
Lawson Kroeker Investment Management Omaha, Nebraska $343M AUM 17.29% 1-Year Est. Return
FCM
Fieldview Capital Management Niles, Michigan $343M AUM 26.32% 1-Year Est. Return
VST
Van Strum & Towne San Francisco, California $343M AUM 14.55% 1-Year Est. Return
CWA
Consilio Wealth Advisors Bellevue, Washington $342M AUM 17.59% 1-Year Est. Return
VRM
Vectors Research Management New York $342M AUM 19.83% 1-Year Est. Return
MJP
Michael J. Puzo $343M AUM 18.42% 1-Year Est. Return
WP
Warburg Pincus New York $343M AUM 18.86% 1-Year Est. Return

M. Kraus & Co's Q3 2016 Portfolio in Review

As of Q3 2016, M. Kraus & Co held 52 positions worth $145M, up 3.4% from $140M the previous quarter. Its ten largest holdings account for 38% of the portfolio.

M. Kraus & Co's Q3 2016 filing shows 2 new, 12 increased, 32 reduced and 2 closed positions. Its largest new stake was Apple: 8,028 shares worth $227K. The largest sale was Johnson & Johnson, an estimated $263K.

By sector, the portfolio is most concentrated in Industrials at 22% of assets, up from 22% a quarter earlier, followed by Healthcare and Consumer Staples.

  • M. Kraus & Co's largest Q3 2016 buy was Apple: 8,028 shares worth $227K.
  • M. Kraus & Co added most to MetLife in Q3 2016, an estimated $1.07M increase.
  • M. Kraus & Co's biggest Q3 2016 reduction was Johnson & Johnson, cutting an estimated $263K.
  • M. Kraus & Co fully exited Bristol-Myers Squibb in Q3 2016, selling an estimated $263K.
  • M. Kraus & Co's ten largest holdings make up 38% of its $145M portfolio in Q3 2016.
  • M. Kraus & Co opened 2 new positions and closed 2 in Q3 2016.
  • M. Kraus & Co's portfolio value rose 3.4% quarter-over-quarter to $145M.

Based on M. Kraus & Co's 13F filing for Q3 2016, filed 19 Oct 2016.